Back
Revance Therapeutics Vs. Anebulo Pharmaceuticals Industry Stock Comparison
Sell
17
RVNC
Revance Therapeutics
Last Price:
3.78
Seasonality Move:
6.97%
Sell
23
ANEB
Anebulo Pharmaceuticals
Last Price:
1.45
Seasonality Move:
20.03%
Sell
17
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $4.02. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
23
Anebulo Pharmaceuticals (ANEB)
is a Sell
Is Anebulo Pharmaceuticals a Buy, Sell or Hold?
- The current Anebulo Pharmaceuticals [ANEB] share price is $1.40. The Score for ANEB is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- ANEB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $4.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.
ANEB Stock Price Chart
What is Anebulo Pharmaceuticals's stock price today?
-
The Anebulo Pharmaceuticals share price today is $1.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANEB is experiencing selling pressure, which indicates risk of future bearish movement.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 39.81 | Sell |
Chaikin Money Flow: | -197589 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.84 - 5.68) | Sell |
Bollinger Bands (100): | (3.83 - 6.27) | Sell |
ANEB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 34.17 | Sell |
Chaikin Money Flow: | -8205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.49 - 1.85) | Sell |
Bollinger Bands (100): | (1.69 - 2.25) | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.89 | Buy |
20-day SMA: | 4.59 | Sell |
50-day SMA: | 5.07 | Sell |
200-day SMA: | 4.58 | Sell |
8-day EMA: | 3.96 | Buy |
20-day EMA: | 4.38 | Sell |
50-day EMA: | 4.85 | Sell |
200-day EMA: | 5.97 | Sell |
ANEB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.49 | Sell |
20-day SMA: | 1.63 | Sell |
50-day SMA: | 1.84 | Sell |
200-day SMA: | 2.28 | Sell |
8-day EMA: | 1.48 | Sell |
20-day EMA: | 1.6 | Sell |
50-day EMA: | 1.77 | Sell |
200-day EMA: | 2.14 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.
Anebulo Pharmaceuticals Earnings Growth & ANEB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.09 per share.
Revance Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Anebulo Pharmaceuticals Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |